GPER1 and Miyoshi myopathy: In this study, for the first time, we investigated the expression pattern of GPER1 in plasma cell dyscrasias, and the functional sequelae underpinning its selective activation using in vitro and in vivo models of MM, a still incurable plasma cell malignancy [23].